Skip to main content
. 2020 Dec 1;60:680–685. doi: 10.1016/j.amsu.2020.11.081

Table 2.

Pathological and clinical characteristics.

Variable All patients
Female
Male
N % N % N %
All 165,465 100.0 73,276 100.0 92,189 100.0
Co-morbidity
None 13,699 8.3 5337 7.3 8362 9.1
1–2 5910 3.6 2662 3.6 3248 3.5
3–4 12,702 7.7 6015 8.2 6687 7.3
>4 133,154 80.5 59,262 80.9 73,892 80.2
SEER Stage
Localized 27,347 16.5 13,621 18.6 13,726 14.9
Regional, direct extension ± lymph nodes 19,960 12.1 8699 11.9 11,261 12.2
Regional, lymph nodes only 14,142 8.5 6365 8.7 7777 8.4
Distant 66,028 39.9 28,354 38.7 37,674 40.9
Unknown/Unstaged 37,988 23.0 16,237 22.2 21,751 23.6
Types of lung cancer
SCLC 20,593 12.4 9874 13.5 10,719 11.6
NSCLC 98,541 59.6 43,338 59.1 55,203 59.9
Other 46,331 28.0 20,064 27.4 26,267 28.5
Grade
Undifferentiated 12,125 7.3 5457 7.4 6668 7.2
Poorly-differentiated 38,048 23.0 15,884 21.7 22,164 24.0
Moderately-differentiated 18,916 11.4 8570 11.7 10,346 11.2
Well-differentiated 5794 3.5 3053 4.2 2741 3.0
Unknown/not stated 90,582 54.7 40,312 55.0 50,270 54.5
Regional Nodes Positive
No 20,141 12.2 9810 13.4 10,331 11.2
Yes 11,890 7.2 5367 7.3 6523 7.1
Unknown 133,434 80.6 58,099 79.3 75,335 81.7
Histologic Type
Adenocarcinoma 45,808 27.7 22,750 31.0 23,058 25.0
Squamous/combine complex 29,336 17.7 10,382 14.2 18,954 20.6
Neuroendocrine 2580 1.6 1523 2.1 1057 1.1
Large cell 7936 4.8 3284 4.5 4652 5.0
Other 15,424 9.3 6690 9.1 8734 9.5
Unknown 64,381 38.9 28,647 39.1 35,734 38.8
Chemotherapy
No 95,994 58.0 43,368 59.2 52,626 57.1
Yes 52,305 31.6 22,954 31.3 29,351 31.8
Unknown 17,166 10.4 6954 9.5 10,212 11.1
Radiation Therapy
No 87,238 52.7 40,605 55.4 46,633 50.6
Yes 65,028 39.3 27,424 37.4 37,604 40.8
Unknown 13,199 8.0 5247 7.2 7952 8.6
Surgery
No 117,283 70.9 51,254 69.9 66,029 71.6
Yes 35,725 21.6 17,087 23.3 18,638 20.2
Unknown 12,457 7.5 4935 6.7 7522 8.2

SCLC = small cell lung cancer, NSCLC = non-small cell lung cancer.